Abiopharma

Lonza Delivers Strong H1 2025 Performance and Upgrades 2025 Full-Year CDMO Sales and Margin Outlook

Financial Statements and Related Announcement: Half Yearly Results

New Form 4 - Natera, Inc. Filed: 2025-07-22 AccNo: 0001415889-25-020160 Size: 9 KB

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

New Form 4 - Natera, Inc. Filed: 2025-07-22 AccNo: 0001415889-25-020159 Size: 9 KB

Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

New Form 4 - Natera, Inc. Filed: 2025-07-22 AccNo: 0001415889-25-020155 Size: 7 KB

New Form 4 - Natera, Inc. Filed: 2025-07-22 AccNo: 0001415889-25-020157 Size: 10 KB

New Form 4 - Natera, Inc. Filed: 2025-07-22 AccNo: 0001415889-25-020158 Size: 15 KB

New Form 4 - Natera, Inc. Filed: 2025-07-22 AccNo: 0001415889-25-020156 Size: 7 KB

New Form 4 - MeiraGTx Holdings plc Filed: 2025-07-22 AccNo: 0001415889-25-020154 Size: 6 KB

Align Technology Announces Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction

Invisalign® Palatal Expander System by Align Technology Now Available in Malaysia for Skeletal and Dental Expansion in Growing Patients

New Form 144 - MeiraGTx Holdings plc Filed: 2025-07-22 AccNo: 0001415889-25-020153 Size: 4 KB